Logo image of HOWL

WEREWOLF THERAPEUTICS INC (HOWL) Stock Earnings & Estimates

NASDAQ:HOWL - US95075A1079 - Common Stock

1.35 USD
0 (0%)
Last: 9/5/2025, 8:20:13 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
HOWL revenue by date.HOWL revenue by date.
16.4M19.943M
21.60%
1.885M
-90.55%

-100.00%
1.897M17.891M
843.12%
75.514M
322.08%
122.77M
62.58%
239.32M
94.93%
288.8M
20.68%
EBITDA
YoY % growth
HOWL ebitda by date.HOWL ebitda by date.
-54.96M
-10.21%
-38.739M
29.51%
-71.78M
-85.29%
-76.123M
-6.05%
-79.662M
-4.65%
-99.654M
-25.10%
-96.186M
3.48%
-71.604M
25.56%
-29.172M
59.26%
N/AN/A
EBIT
YoY % growth
HOWL ebit by date.HOWL ebit by date.
-56.06M
-11.92%
-40.503M
27.75%
-73.594M
-81.70%
-74.631M
-1.41%
-77.762M
-4.20%
-107.452M
-38.18%
-139.297M
-29.64%
-83.124M
40.33%
-16.286M
80.41%
80.529M
594.46%
134.74M
67.32%
Operating Margin
HOWL operating margin by date.HOWL operating margin by date.
-341.83%-203.09%-3,904.19%N/AN/A-5,664.31%-778.59%-110.08%-13.27%33.65%46.66%
EPS
YoY % growth
HOWL eps by date.HOWL eps by date.
-1.88
97.87%
-1.04
44.68%
-1.63
-56.73%
-1.79
-9.93%
-1.59
11.48%
-1.93
-21.93%
-1.75
9.55%
-1.12
36.15%
-0.53
52.97%
0.37
169.90%
0.87
136.11%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.40
-6.29%
-0.39
14.85%
-0.38
5.65%
-0.39
3.10%
-0.52
-29.63%
-0.52
-31.95%
-0.40
-5.41%
-0.45
-17.11%
-0.52
0.84%
-0.53
-1.64%
Revenue
Q2Q % growth
N/AN/AN/AN/A
EBITDA
Q2Q % growth
-18.411M
-16.88%
-18.615M
-0.44%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-18.487M
-7.96%
-19.877M
2.31%
-18.574M
-3.24%
-18.807M
-7.21%
-19.801M
-7.11%
-20.055M
-0.90%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.40 -0.490.0917.61%
Q1 2025
Q2Q % growth
-0.40
-2.56%
-0.400.000.47%
Q4 2024
Q2Q % growth
-0.46
-39.39%
-0.43-0.03-7.80%
Q3 2024
Q2Q % growth
-0.38
-65.22%
-0.420.049.61%
Q2 2024
Q2Q % growth
-0.40
-185.71%
-0.38-0.02-4.30%
Q1 2024
Q2Q % growth
-0.39
-14.71%
-0.36-0.03-9.56%
Q4 2023
Q2Q % growth
-0.33
15.38%
-0.440.1125.39%
Q3 2023
Q2Q % growth
-0.23
42.50%
-0.400.1742.88%
Q2 2023
Q2Q % growth
-0.14
73.58%
-0.430.2967.48%
Q1 2023
Q2Q % growth
-0.34
39.29%
-0.510.1733.33%
Q4 2022
Q2Q % growth
-0.39
40.91%
-0.560.1729.97%
Q3 2022
Q2Q % growth
-0.40
21.57%
-0.610.2134.91%
Q2 2022
Q2Q % growth
-0.53
86.13%
-0.44-0.09-21.55%
Q1 2022
Q2Q % growth
-0.56
99.33%
-0.630.0710.73%
Q4 2021
Q2Q % growth
-0.66 -0.54-0.12-22.09%
Q3 2021
Q2Q % growth
-0.51 -0.45-0.06-12.36%
Q2 2021
Q2Q % growth
-3.82 -0.37-3.45-921.38%
Q1 2021
Q2Q % growth
-83.36 -0.47-82.89-17,666.41%
HOWL Yearly EPS VS EstimatesHOWL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -20 -40 -60 -80
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth

-100.00%
%
Q1 2025
Q2Q % growth

-100.00%
306K-306K-100.00%
Q4 2024
Q2Q % growth

-100.00%
307.703K-307.703K-100.00%
Q3 2024
Q2Q % growth

-100.00%
724.2K-724.2K-100.00%
Q2 2024
Q2Q % growth
1.143M
-85.86%
858.84K284.16K33.09%
Q1 2024
Q2Q % growth
742K
-83.38%
1.859M-1.117M-60.09%
Q4 2023
Q2Q % growth
1.501M
-79.38%
1.983M-482K-24.31%
Q3 2023
Q2Q % growth
5.897M
18.65%
1.624M4.273M263.12%
Q2 2023
Q2Q % growth
8.081M
94.72%
2.512M5.569M221.70%
Q1 2023
Q2Q % growth
4.464M 5.1M-636K-12.47%
Q4 2022
Q2Q % growth
7.28M 2.114M5.166M244.37%
HOWL Yearly Revenue VS EstimatesHOWL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS13.16% 17.5% 0.98% 2.5%
RevenueN/A -100% N/A -100%